Atria Wealth Solutions, Inc. Assertio Holdings, Inc. Transaction History

Atria Wealth Solutions, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	BUY	$5.0 - $7.66 $1.48 Million - $2.26 Million	295,464 Added 1163.84%	320,851 $1.74 Million
Q1 2023 Aug 22, 2023	SELL	$3.54 - $6.66 $1.05 Million - $1.97 Million	-295,806 Reduced 92.19%	25,045 $159,000
Q1 2023 Jun 14, 2023	BUY	$3.54 - $6.66 $1,210 - $2,277	342 Added 1.37%	25,387 $161,000
Q1 2023 May 10, 2023	SELL	$3.54 - $6.66 $1,210 - $2,277	-342 Reduced 1.35%	25,045 $159,000
Q4 2022 Aug 30, 2023	SELL	$2.11 - $4.3 $623,429 - $1.27 Million	-295,464 Reduced 92.09%	25,387 $109,000
Q4 2022 Feb 13, 2023	BUY	$2.11 - $4.3 $21,916 - $44,664	10,387 Added 69.25%	25,387 $109,000
Q3 2022 Nov 14, 2022	BUY	$2.13 - $4.0 $31,950 - $60,000	15,000 New	15,000 $34,000
Q2 2022 Aug 15, 2022	SELL	$1.88 - $3.42 $28,200 - $51,300	-15,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.06 - $3.0 $30,900 - $45,000	15,000 New	15,000 $43,000

114

37.2M

755K

39.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $58.8M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.